Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments
暂无分享,去创建一个
Natalie von Goetz | Konrad Hungerbuehler | Alke Petri-Fink | Barbara Rothen-Rutishauser | Sabrina Losert | Yuki Umehara | B. Rothen‐Rutishauser | N. von Goetz | A. Petri‐Fink | L. Rodríguez-Lorenzo | S. Losert | G. Bachler | Laura Rodriguez-Lorenzo | Gerald Bachler | K. Hungerbuehler | Y. Umehara
[1] Jürgen Seitz,et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs , 2009, Inhalation toxicology.
[2] R. Müller,et al. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns , 2005, Journal of drug targeting.
[3] Konrad Hungerbühler,et al. A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles , 2013, International journal of nanomedicine.
[4] Peter Gehr,et al. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. , 2005, American journal of respiratory cell and molecular biology.
[5] C. Migliaresi,et al. Gold nanoparticles: role of size and surface chemistry on blood protein adsorption , 2013, Journal of Nanoparticle Research.
[6] B. Lehnert,et al. Correlation between particle size, in vivo particle persistence, and lung injury. , 1994, Environmental health perspectives.
[7] Andrew Emili,et al. Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. , 2014, ACS nano.
[8] L. Chin,et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. , 1994, American journal of respiratory cell and molecular biology.
[9] Catherine J. Murphy,et al. Seed‐Mediated Growth Approach for Shape‐Controlled Synthesis of Spheroidal and Rod‐like Gold Nanoparticles Using a Surfactant Template , 2001 .
[10] Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection. , 1994, Annals of the ICRP.
[11] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[12] Nicklas Raun Jacobsen,et al. Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation , 2009, Chemistry Central journal.
[13] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[14] V. H. Lee,et al. Monolayers of Human Alveolar Epithelial Cells in Primary Culture for Pulmonary Absorption and Transport Studies , 1999, Pharmaceutical Research.
[15] S. Vepřek,et al. Industrial applications of superhard nanocomposite coatings , 2008 .
[16] I. Zuhorn,et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.
[17] J. Jung,et al. Twenty-Eight-Day Inhalation Toxicity Study of Silver Nanoparticles in Sprague-Dawley Rats , 2007, Inhalation toxicology.
[18] M. Kandlikar,et al. The impact of toxicity testing costs on nanomaterial regulation. , 2009, Environmental science & technology.
[19] Joel G Pounds,et al. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.
[20] S. Hamm-Alvarez,et al. Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers , 2011, International journal of nanomedicine.
[21] Seiko F. Okada,et al. Human Alveolar Type II Cells Secrete and Absorb Liquid in Response to Local Nucleotide Signaling* , 2010, The Journal of Biological Chemistry.
[22] Barry H. Smith,et al. A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.
[23] K. Hungerbuhler,et al. Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles , 2015, Nanotoxicology.
[24] M. Davis,et al. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. , 1976, Environmental research.
[25] M. Natan,et al. Seeding of Colloidal Au Nanoparticle Solutions. 2. Improved Control of Particle Size and Shape , 2000 .
[26] E. Fröhlich,et al. Toxicological Assessment of Inhaled Nanoparticles: Role of in Vivo, ex Vivo, in Vitro, and in Silico Studies , 2014, International journal of molecular sciences.
[27] Lev Dykman,et al. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.
[28] R. MacCuspie,et al. Colloidal stability of silver nanoparticles in biologically relevant conditions , 2011 .
[29] M D Blaufox,et al. Blood volume in the rat. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] B. van Ravenzwaay,et al. Development of a Short-Term Inhalation Test in the Rat Using Nano-Titanium Dioxide as a Model Substance , 2009 .
[31] J. Sharp,et al. Blood volume determination in the mouse , 1973, The Journal of physiology.
[32] Joel G Pounds,et al. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[33] Hemant Sarin,et al. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability , 2010, Journal of angiogenesis research.
[34] J. Whitsett,et al. Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] Icrp. Human Respiratory Tract Model for Radiological Protection , 1994 .
[36] M. Wiemann,et al. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials , 2014, Particle and Fibre Toxicology.
[37] Kwang-Jin Kim,et al. Nanoparticle translocation across mouse alveolar epithelial cell monolayers: species-specific mechanisms. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[38] Marianne Geiser,et al. Particle Retention in Airways by Surfactant , 1990 .
[39] Peter Gehr,et al. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. , 2007, American journal of respiratory cell and molecular biology.
[40] Martin Mohr,et al. Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways , 2010, Journal of The Royal Society Interface.
[41] Claus-Michael Lehr,et al. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier. , 2014, Molecular pharmaceutics.
[42] D. Fernig,et al. Determination of size and concentration of gold nanoparticles from UV-vis spectra. , 2007, Analytical chemistry.
[43] S. Schürch,et al. Surfactant displaces particles toward the epithelium in airways and alveoli. , 1990, Respiration physiology.
[44] Robert C MacPhail,et al. Engineered nanomaterials: exposures, hazards, and risk prevention , 2011, Journal of occupational medicine and toxicology.
[45] T. Gray,et al. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. , 1996, Gut.
[46] Jochen Schmidt,et al. Dissolution kinetics of titanium dioxide nanoparticles: the observation of an unusual kinetic size effect. , 2006, The journal of physical chemistry. B.
[47] R. G. Freeman,et al. Preparation and Characterization of Au Colloid Monolayers , 1995 .
[48] Claus-Michael Lehr,et al. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[49] Noah Malmstadt,et al. Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles. , 2010, American journal of respiratory cell and molecular biology.
[50] Dennis E. Koppel,et al. Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .
[51] Pedro J. J. Alvarez,et al. Nanomaterials in the construction industry: a review of their applications and environmental health and safety considerations. , 2010, ACS nano.
[52] M. Sakagami,et al. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. , 2006, Advanced drug delivery reviews.
[53] B. Rothen‐Rutishauser,et al. An optimized in vitro model of the respiratory tract wall to study particle cell interactions. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[54] Albert Duschl,et al. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle , 2013, Journal of Nanobiotechnology.
[55] Robert Landsiedel,et al. Toxico-/biokinetics of nanomaterials , 2012, Archives of Toxicology.
[56] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[57] Elazer R. Edelman,et al. Adv. Drug Delivery Rev. , 1997 .
[58] Konrad Hungerbühler,et al. Nanosized aerosols from consumer sprays: experimental analysis and exposure modeling for four commercial products , 2011 .
[59] Jin Sik Kim,et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. , 2008, Inhalation toxicology.
[60] K. Plate,et al. Differentiation of the brain vasculature: the answer came blowing by the Wnt , 2010, Journal of angiogenesis research.
[61] W. Stott,et al. Blood‐flow distribution in the mouse , 1983, Journal of applied toxicology : JAT.
[62] W. Thompson,et al. Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+and permeability. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[63] N. Nugent,et al. European Commission , 1993, European Energy and Environmental Law Review.
[64] Linsey C Marr,et al. Silver nanoparticles and total aerosols emitted by nanotechnology-related consumer spray products. , 2011, Environmental science & technology.
[65] Fabian Herzog,et al. Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface , 2013, Particle and Fibre Toxicology.
[66] S. Vranic,et al. Development of an in vitro model of human bronchial epithelial barrier to study nanoparticle translocation. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[67] R. van Furth,et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. , 1972, Bulletin of the World Health Organization.
[68] W. Kreyling,et al. Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. , 2013, Journal of aerosol medicine and pulmonary drug delivery.
[69] Hans Bouwmeester,et al. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. , 2011, ACS nano.
[70] Y. Korchev,et al. Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. , 2008, American journal of respiratory cell and molecular biology.
[71] Hak Soo Choi,et al. Rapid translocation of nanoparticles from the lung airspaces to the body , 2010, Nature Biotechnology.
[72] Philip Demokritou,et al. Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro , 2014, Nanotoxicology.
[73] S. Hamm-Alvarez,et al. Polystyrene nanoparticle trafficking across alveolar epithelium. , 2008, Nanomedicine : nanotechnology, biology, and medicine.
[74] O. Schmid,et al. Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. , 2010, Toxicology and applied pharmacology.
[75] Manuela Semmler-Behnke,et al. Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. , 2014, ACS nano.
[76] Manuela Semmler-Behnke,et al. Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.
[77] K. Audus,et al. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. , 1998, Experimental cell research.
[78] W. Kreyling,et al. Pulmonary surfactant is indispensable in order to simulate the in vivo situation , 2013, Particle and Fibre Toxicology.
[79] C. Murphy,et al. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.
[80] Paul J Lioy,et al. Potential for exposure to engineered nanoparticles from nanotechnology-based consumer spray products , 2011, Journal of Exposure Science and Environmental Epidemiology.
[81] Elodie Boisselier,et al. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.
[82] W. D. de Jong,et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. , 2010, Biomaterials.
[83] O. Feron,et al. Antibody immobilization on gold nanoparticles coated layer-by-layer with polyelectrolytes , 2011 .
[84] C. Kranz,et al. Fusion‐activated cation entry (FACE) via P2X4 couples surfactant secretion and alveolar fluid transport , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[85] W. Kreyling,et al. TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOW , 2002, Journal of toxicology and environmental health. Part A.
[86] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[87] Manuela Semmler-Behnke,et al. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.
[88] P. Prasad,et al. Synthesis and plasmonic properties of silver and gold nanoshells on polystyrene cores of different size and of gold-silver core-shell nanostructures , 2006 .
[89] Barbara Rothen-Rutishauser,et al. A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles , 2009, Particle and Fibre Toxicology.